BioMarin Pharmaceuticals
BMRN
BMRN
550 hedge funds and large institutions have $15.6B invested in BioMarin Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 63 funds opening new positions, 216 increasing their positions, 176 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
7% more capital invested
Capital invested by funds: $14.7B → $15.6B (+$969M)
3.71% more ownership
Funds ownership: 96.74% → 100.46% (+3.7%)
2% more funds holding
Funds holding: 541 → 550 (+9)
Holders
550
Holding in Top 10
13
Calls
$134M
Puts
$101M
Top Buyers
| 1 | +$361M | |
| 2 | +$129M | |
| 3 | +$87.9M | |
| 4 |
Man Group
London,
United Kingdom
|
+$48.8M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$39.8M |
Top Sellers
| 1 | -$141M | |
| 2 | -$62.3M | |
| 3 | -$46.7M | |
| 4 |
UBS AM
Chicago,
Illinois
|
-$25.7M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$24.9M |